Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
NCT ID: NCT05305261
Last Updated: 2022-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
197 participants
OBSERVATIONAL
2021-07-29
2022-03-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Passive Transmission of COVID-19 Antibody From Mother to Infant
NCT05851911
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533
Priming of the NEonatal Immune System by Transfer of Maternal Immunity
NCT05429047
Investigation of the Passage of Antiviral Antibodies From Mother to Child
NCT05821764
Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium
NCT05618548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* vaccinated 2 doses
* in labour
Exclusion Criteria
* preterm labour less than 37 weeks
* multiple pregnancies
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malaysia Automotive Robotics and Innovation of Technology Institute
UNKNOWN
National University of Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rahana Abd Rahman
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UKM Medical Center
Kuala Lumpur, W.Persekutuan, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF-2021-362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.